APO Research
Talk to an analyst

APO RESEARCH · REPORT

Polymer Coronary Stents

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Polymer Coronary Stents Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

26 December 2025193 pages

Choose your research edition.

Industry ResearchPolymer Coronary Stents Industry Research Report 2026133 pages · $2,950 USDIndustry Growth & TrendsGlobal Polymer Coronary Stents Industry Growth and Trends Forecast to 2032110 pages · $3,450 USDMarket StructureGlobal Polymer Coronary Stents Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Polymer Coronary Stents Market Outlook and Growth Opportunities 2026206 pages · $4,250 USDMarket Analysis & ForecastGlobal Polymer Coronary Stents Market Analysis and Forecast 2026-2032209 pages · $4,950 USD

Market perspective

The global Polymer Coronary Stents market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Polymer Coronary Stents is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Polymer Coronary Stents is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Polymer Coronary Stents is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Polymer Coronary Stents is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Polymer Coronary Stents include Wego Healthcare, Shandong Huaan Biotechnology, SINOMED, Translumina Therapeutics, SLTL Medical, Scitech Medical, Rontis, REVA Medical and Purple Microport, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Polymer Coronary Stents market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Polymer Coronary Stents and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Polymer Coronary Stents sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Polymer Coronary Stents market size, projected growth trends, production technologies, key applications, and end-use industries.

Polymer Coronary Stents Segment by Company

Wego Healthcare

Shandong Huaan Biotechnology

SINOMED

Translumina Therapeutics

SLTL Medical

Scitech Medical

Rontis

REVA Medical

Purple Microport

Meril Life

InSitu Technologies

HEALTHCARE TECHNOLOGY

Eucatech

Elixir Medical

CeloNova BioSciences

Biotronik

AMG International

Amaranth Medical Analytics

Alvimedica

Polymer Coronary Stents Segment by Type

Hybrid Stents

Biodegradable Polymer Stents

Resorbable Polymer Stents

Bare Metal Polymer Stents

Drug-Eluting Polymer Stents

Polymer Coronary Stents Segment by Application

Drug-Eluting

Post-Procedure Management

Percutaneous Coronary Intervention (PCI)

Polymer Coronary Stents Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Polymer Coronary Stents market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Polymer Coronary Stents and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Polymer Coronary Stents.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Polymer Coronary Stents market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Polymer Coronary Stents manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Polymer Coronary Stents in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Polymer Coronary Stents in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Polymer Coronary Stents Industry Trends Table 2. Polymer Coronary Stents Industry Drivers Table 3. Polymer Coronary Stents Industry Opportunities and Challenges Table 4. Polymer Coronary Stents Industry Restraints Table 5. Global Polymer Coronary Stents Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Polymer Coronary Stents Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Polymer Coronary Stents Sales by Manufacturers (Units) & (2021-2026) Table 8. Global Polymer Coronary Stents Sales Market Share by Manufacturers Table 9. Global Polymer Coronary Stents Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Polymer Coronary Stents Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Polymer Coronary Stents Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Polymer Coronary Stents Manufacturers, Product Type & Application Table 13. Global Polymer Coronary Stents Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Polymer Coronary Stents by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Hybrid Stents Table 17. Major Manufacturers of Biodegradable Polymer Stents Table 18. Major Manufacturers of Resorbable Polymer Stents Table 19. Major Manufacturers of Bare Metal Polymer Stents Table 20. Major Manufacturers of Drug-Eluting Polymer Stents Table 21. Global Polymer Coronary Stents Sales by Type 2021 VS 2025 VS 2032 (Units) Table 22. Global Polymer Coronary Stents Sales by Type (2021-2026) & (Units) Table 23. Global Polymer Coronary Stents Sales by Type (2027-2032) & (Units) Table 24. Global Polymer Coronary Stents Sales Market Share by Type (2021-2026) Table 25. Global Polymer Coronary Stents Sales Market Share by Type (2027-2032) Table 26. Global Polymer Coronary Stents Revenue by Type 2021 VS 2025 VS 2032 (Units) Table 27. Global Polymer Coronary Stents Revenue by Type (2021-2026) & (Units) Table 28. Global Polymer Coronary Stents Revenue by Type (2027-2032) & (Units) Table 29. Global Polymer Coronary Stents Revenue Market Share by Type (2021-2026) Table 30. Global Polymer Coronary Stents Revenue Market Share by Type (2027-2032) Table 31. Major Manufacturers of Drug-Eluting Table 32. Major Manufacturers of Post-Procedure Management Table 33. Major Manufacturers of Percutaneous Coronary Intervention (PCI) Table 34. Global Polymer Coronary Stents Sales by Application 2021 VS 2025 VS 2032 (Units) Table 35. Global Polymer Coronary Stents Sales by Application (2021-2026) & (Units) Table 36. Global Polymer Coronary Stents Sales by Application (2027-2032) & (Units) Table 37. Global Polymer Coronary Stents Sales Market Share by Application (2021-2026) Table 38. Global Polymer Coronary Stents Sales Market Share by Application (2027-2032) Table 39. Global Polymer Coronary Stents Revenue by Application 2021 VS 2025 VS 2032 (Units) Table 40. Global Polymer Coronary Stents Revenue by Application (2021-2026) & (Units) Table 41. Global Polymer Coronary Stents Revenue by Application (2027-2032) & (Units) Table 42. Global Polymer Coronary Stents Revenue Market Share by Application (2021-2026) Table 43. Global Polymer Coronary Stents Revenue Market Share by Application (2027-2032) Table 44. Global Polymer Coronary Stents Sales by Region: 2021 VS 2025 VS 2032 (Units) Table 45. Global Polymer Coronary Stents Sales by Region (2021-2026) & (Units) Table 46. Global Polymer Coronary Stents Sales Market Share by Region (2021-2026) Table 47. Global Polymer Coronary Stents Sales Forecasted by Region (2027-2032) & (Units) Table 48. Global Polymer Coronary Stents Sales Forecasted Market Share by Region (2027-2032) Table 49. North America Polymer Coronary Stents Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Units) Table 50. North America Polymer Coronary Stents Sales by Country (2021-2026) & (Units) Table 51. North America Polymer Coronary Stents Sales by Country (2027-2032) & (Units) Table 52. Europe Polymer Coronary Stents Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Units) Table 53. Europe Polymer Coronary Stents Sales by Country (2021-2026) & (Units) Table 54. Europe Polymer Coronary Stents Sales by Country (2027-2032) & (Units) Table 55. Asia Pacific Polymer Coronary Stents Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Units) Table 56. Asia Pacific Polymer Coronary Stents Sales by Country (2021-2026) & (Units) Table 57. Asia Pacific Polymer Coronary Stents Sales by Country (2027-2032) & (Units) Table 58. South America, Middle East and Africa Polymer Coronary Stents Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Units) Table 59. South America, Middle East and Africa Polymer Coronary Stents Sales by Country (2021-2026) & (Units) Table 60. South America, Middle East and Africa Polymer Coronary Stents Sales by Country (2027-2032) & (Units) Table 61. Global Polymer Coronary Stents Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 62. Global Polymer Coronary Stents Revenue by Region (2021-2026) & (US$ Million) Table 63. Global Polymer Coronary Stents Revenue by Region (2027-2032) & (US$ Million) Table 64. Global Polymer Coronary Stents Revenue Market Share by Region (2021-2026) Table 65. Global Polymer Coronary Stents Revenue Market Share by Region (2027-2032) Table 66. Wego Healthcare Company Information Table 67. Wego Healthcare Business Overview Table 68. Wego Healthcare Polymer Coronary Stents Sales (Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. Wego Healthcare Polymer Coronary Stents Product Portfolio Table 70. Wego Healthcare Recent Development Table 71. Shandong Huaan Biotechnology Company Information Table 72. Shandong Huaan Biotechnology Business Overview Table 73. Shandong Huaan Biotechnology Polymer Coronary Stents Sales (Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. Shandong Huaan Biotechnology Polymer Coronary Stents Product Portfolio Table 75. Shandong Huaan Biotechnology Recent Development Table 76. SINOMED Company Information Table 77. SINOMED Business Overview Table 78. SINOMED Polymer Coronary Stents Sales (Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. SINOMED Polymer Coronary Stents Product Portfolio Table 80. SINOMED Recent Development Table 81. Translumina Therapeutics Company Information Table 82. Translumina Therapeutics Business Overview Table 83. Translumina Therapeutics Polymer Coronary Stents Sales (Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. Translumina Therapeutics Polymer Coronary Stents Product Portfolio Table 85. Translumina Therapeutics Recent Development Table 86. SLTL Medical Company Information Table 87. SLTL Medical Business Overview Table 88. SLTL Medical Polymer Coronary Stents Sales (Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. SLTL Medical Polymer Coronary Stents Product Portfolio Table 90. SLTL Medical Recent Development Table 91. Scitech Medical Company Information Table 92. Scitech Medical Business Overview Table 93. Scitech Medical Polymer Coronary Stents Sales (Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 94. Scitech Medical Polymer Coronary Stents Product Portfolio Table 95. Scitech Medical Recent Development Table 96. Rontis Company Information Table 97. Rontis Business Overview Table 98. Rontis Polymer Coronary Stents Sales (Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 99. Rontis Polymer Coronary Stents Product Portfolio Table 100. Rontis Recent Development Table 101. REVA Medical Company Information Table 102. REVA Medical Business Overview Table 103. REVA Medical Polymer Coronary Stents Sales (Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 104. REVA Medical Polymer Coronary Stents Product Portfolio Table 105. REVA Medical Recent Development Table 106. Purple Microport Company Information Table 107. Purple Microport Business Overview Table 108. Purple Microport Polymer Coronary Stents Sales (Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 109. Purple Microport Polymer Coronary Stents Product Portfolio Table 110. Purple Microport Recent Development Table 111. Meril Life Company Information Table 112. Meril Life Business Overview Table 113. Meril Life Polymer Coronary Stents Sales (Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 114. Meril Life Polymer Coronary Stents Product Portfolio Table 115. Meril Life Recent Development Table 116. InSitu Technologies Company Information Table 117. InSitu Technologies Business Overview Table 118. InSitu Technologies Polymer Coronary Stents Sales (Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 119. InSitu Technologies Polymer Coronary Stents Product Portfolio Table 120. InSitu Technologies Recent Development Table 121. HEALTHCARE TECHNOLOGY Company Information Table 122. HEALTHCARE TECHNOLOGY Business Overview Table 123. HEALTHCARE TECHNOLOGY Polymer Coronary Stents Sales (Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 124. HEALTHCARE TECHNOLOGY Polymer Coronary Stents Product Portfolio Table 125. HEALTHCARE TECHNOLOGY Recent Development Table 126. Eucatech Company Information Table 127. Eucatech Business Overview Table 128. Eucatech Polymer Coronary Stents Sales (Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 129. Eucatech Polymer Coronary Stents Product Portfolio Table 130. Eucatech Recent Development Table 131. Elixir Medical Company Information Table 132. Elixir Medical Business Overview Table 133. Elixir Medical Polymer Coronary Stents Sales (Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 134. Elixir Medical Polymer Coronary Stents Product Portfolio Table 135. Elixir Medical Recent Development Table 136. CeloNova BioSciences Company Information Table 137. CeloNova BioSciences Business Overview Table 138. CeloNova BioSciences Polymer Coronary Stents Sales (Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 139. CeloNova BioSciences Polymer Coronary Stents Product Portfolio Table 140. CeloNova BioSciences Recent Development Table 141. Biotronik Company Information Table 142. Biotronik Business Overview Table 143. Biotronik Polymer Coronary Stents Sales (Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 144. Biotronik Polymer Coronary Stents Product Portfolio Table 145. Biotronik Recent Development Table 146. AMG International Company Information Table 147. AMG International Business Overview Table 148. AMG International Polymer Coronary Stents Sales (Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 149. AMG International Polymer Coronary Stents Product Portfolio Table 150. AMG International Recent Development Table 151. Amaranth Medical Analytics Company Information Table 152. Amaranth Medical Analytics Business Overview Table 153. Amaranth Medical Analytics Polymer Coronary Stents Sales (Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 154. Amaranth Medical Analytics Polymer Coronary Stents Product Portfolio Table 155. Amaranth Medical Analytics Recent Development Table 156. Alvimedica Company Information Table 157. Alvimedica Business Overview Table 158. Alvimedica Polymer Coronary Stents Sales (Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 159. Alvimedica Polymer Coronary Stents Product Portfolio Table 160. Alvimedica Recent Development Table 161. Key Raw Materials Table 162. Raw Materials Key Suppliers Table 163. Polymer Coronary Stents Distributors List Table 164. Polymer Coronary Stents Customers List Table 165. Research Programs/Design for This Report Table 166. Authors List of This Report Table 167. Secondary Sources Table 168. Primary Sources List of Figures Figure 1. Polymer Coronary Stents Product Image Figure 2. Global Polymer Coronary Stents Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Polymer Coronary Stents Market Size (2021-2032) & (US$ Million) Figure 4. Global Polymer Coronary Stents Sales (2021-2032) & (Units) Figure 5. Global Polymer Coronary Stents Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Polymer Coronary Stents Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Hybrid Stents Image Figure 9. Biodegradable Polymer Stents Image Figure 10. Resorbable Polymer Stents Image Figure 11. Bare Metal Polymer Stents Image Figure 12. Drug-Eluting Polymer Stents Image Figure 13. Global Polymer Coronary Stents Sales by Type (2021 VS 2025 VS 2032) & (Units) Figure 14. Global Polymer Coronary Stents Sales Market Share 2021 VS 2025 VS 2032 Figure 15. Global Polymer Coronary Stents Sales Market Share by Type (2021-2032) Figure 16. Global Polymer Coronary Stents Revenue by Type (2021 VS 2025 VS 2032) & (Units) Figure 17. Global Polymer Coronary Stents Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global Polymer Coronary Stents Revenue Market Share by Type (2021-2032) Figure 19. Drug-Eluting Image Figure 20. Post-Procedure Management Image Figure 21. Percutaneous Coronary Intervention (PCI) Image Figure 22. Global Polymer Coronary Stents Sales by Application (2021 VS 2025 VS 2032) & (Units) Figure 23. Global Polymer Coronary Stents Sales Market Share 2021 VS 2025 VS 2032 Figure 24. Global Polymer Coronary Stents Sales Market Share by Application (2021-2032) Figure 25. Global Polymer Coronary Stents Revenue by Application (2021 VS 2025 VS 2032) & (Units) Figure 26. Global Polymer Coronary Stents Revenue Market Share 2021 VS 2025 VS 2032 Figure 27. Global Polymer Coronary Stents Revenue Market Share by Application (2021-2032) Figure 28. North America Polymer Coronary Stents Sales and Growth Rate (2021-2032) & (Units) Figure 29. North America Polymer Coronary Stents Sales Market Share by Country (2021-2032) Figure 30. U.S. Polymer Coronary Stents Sales and Growth Rate (2021-2032) & (Units) Figure 31. Canada Polymer Coronary Stents Sales and Growth Rate (2021-2032) & (Units) Figure 32. Mexico Polymer Coronary Stents Sales and Growth Rate (2021-2032) & (Units) Figure 33. Europe Polymer Coronary Stents Sales and Growth Rate (2021-2032) & (Units) Figure 34. Europe Polymer Coronary Stents Sales Market Share by Country (2021-2032) Figure 35. Germany Polymer Coronary Stents Sales and Growth Rate (2021-2032) & (Units) Figure 36. France Polymer Coronary Stents Sales and Growth Rate (2021-2032) & (Units) Figure 37. U.K. Polymer Coronary Stents Sales and Growth Rate (2021-2032) & (Units) Figure 38. Italy Polymer Coronary Stents Sales and Growth Rate (2021-2032) & (Units) Figure 39. Netherlands Polymer Coronary Stents Sales and Growth Rate (2021-2032) & (Units) Figure 40. Asia Pacific Polymer Coronary Stents Sales and Growth Rate (2021-2032) & (Units) Figure 41. Asia Pacific Polymer Coronary Stents Sales Market Share by Country (2021-2032) Figure 42. China Polymer Coronary Stents Sales and Growth Rate (2021-2032) & (Units) Figure 43. Japan Polymer Coronary Stents Sales and Growth Rate (2021-2032) & (Units) Figure 44. South Korea Polymer Coronary Stents Sales and Growth Rate (2021-2032) & (Units) Figure 45. Southeast Asia Polymer Coronary Stents Sales and Growth Rate (2021-2032) & (Units) Figure 46. India Polymer Coronary Stents Sales and Growth Rate (2021-2032) & (Units) Figure 47. Australia Polymer Coronary Stents Sales and Growth Rate (2021-2032) & (Units) Figure 48. South America, Middle East and Africa Polymer Coronary Stents Sales and Growth Rate (2021-2032) & (Units) Figure 49. South America, Middle East and Africa Polymer Coronary Stents Sales Market Share by Country (2021-2032) Figure 50. Brazil Polymer Coronary Stents Sales and Growth Rate (2021-2032) & (Units) Figure 51. South Africa Polymer Coronary Stents Sales and Growth Rate (2021-2032) & (Units) Figure 52. Saudi Arabia Polymer Coronary Stents Sales and Growth Rate (2021-2032) & (Units) Figure 53. Turkey Polymer Coronary Stents Sales and Growth Rate (2021-2032) & (Units) Figure 54. Argentina Polymer Coronary Stents Sales and Growth Rate (2021-2032) & (Units) Figure 55. UAE Polymer Coronary Stents Sales and Growth Rate (2021-2032) & (Units) Figure 56. Egypt Polymer Coronary Stents Sales and Growth Rate (2021-2032) & (Units) Figure 57. Chile Polymer Coronary Stents Sales and Growth Rate (2021-2032) & (Units) Figure 58. Global Polymer Coronary Stents Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 59. Global Polymer Coronary Stents Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 60. North America Polymer Coronary Stents Revenue (2021-2032) & (US$ Million) Figure 61. North America Polymer Coronary Stents Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Europe Polymer Coronary Stents Revenue (2021-2032) & (US$ Million) Figure 63. Europe Polymer Coronary Stents Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Asia-Pacific Polymer Coronary Stents Revenue (2021-2032) & (US$ Million) Figure 65. Asia-Pacific Polymer Coronary Stents Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. South America, Middle East and Africa Polymer Coronary Stents Revenue (2021-2032) & (US$ Million) Figure 67. South America, Middle East and Africa Polymer Coronary Stents Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 68. Polymer Coronary Stents Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Polymer Coronary Stents Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Hybrid Stents
  • Biodegradable Polymer Stents
  • Resorbable Polymer Stents
  • Bare Metal Polymer Stents
  • Drug-Eluting Polymer Stents
Applications
  • Drug-Eluting
  • Post-Procedure Management
  • Percutaneous Coronary Intervention (PCI)
Companies covered
  • Wego Healthcare
  • Shandong Huaan Biotechnology
  • SINOMED
  • Translumina Therapeutics
  • SLTL Medical
  • Scitech Medical
  • Rontis
  • REVA Medical
  • Purple Microport
  • Meril Life
  • InSitu Technologies
  • HEALTHCARE TECHNOLOGY
  • Eucatech
  • Elixir Medical
  • CeloNova BioSciences
  • Biotronik
  • AMG International
  • Amaranth Medical Analytics
  • Alvimedica

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Polymer Coronary Stents Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Polymer Coronary Stents Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Polymer Coronary Stents Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Polymer Coronary Stents Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Polymer Coronary Stents Market Dynamics
  1. 2.1 Polymer Coronary Stents Industry Trends
  2. 2.2 Polymer Coronary Stents Industry Drivers
  3. 2.3 Polymer Coronary Stents Industry Opportunities and Challenges
  4. 2.4 Polymer Coronary Stents Industry Restraints
3 Polymer Coronary Stents Market by Manufacturers
  1. 3.1 Global Polymer Coronary Stents Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Polymer Coronary Stents Sales by Manufacturers (2021-2026)
  3. 3.3 Global Polymer Coronary Stents Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Polymer Coronary Stents Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Polymer Coronary Stents Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Polymer Coronary Stents Manufacturers, Product Type & Application
  7. 3.7 Global Polymer Coronary Stents Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Polymer Coronary Stents Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Polymer Coronary Stents Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Polymer Coronary Stents Tier 1, Tier 2, and Tier 3
4 Polymer Coronary Stents Market by Type
  1. 4.1 Polymer Coronary Stents Type Introduction
  2. 4.1.1 Hybrid Stents
  3. 4.1.2 Biodegradable Polymer Stents
  4. 4.1.3 Resorbable Polymer Stents
  5. 4.1.4 Bare Metal Polymer Stents
  6. 4.1.5 Drug-Eluting Polymer Stents
  7. 4.2 Global Polymer Coronary Stents Sales by Type
  8. 4.2.1 Global Polymer Coronary Stents Sales by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Polymer Coronary Stents Sales by Type (2021-2032)
  10. 4.2.3 Global Polymer Coronary Stents Sales Market Share by Type (2021-2032)
  11. 4.3 Global Polymer Coronary Stents Revenue by Type
  12. 4.3.1 Global Polymer Coronary Stents Revenue by Type (2021 VS 2025 VS 2032)
  13. 4.3.2 Global Polymer Coronary Stents Revenue by Type (2021-2032)
  14. 4.3.3 Global Polymer Coronary Stents Revenue Market Share by Type (2021-2032)
5 Polymer Coronary Stents Market by Application
  1. 5.1 Polymer Coronary Stents Application Introduction
  2. 5.1.1 Drug-Eluting
  3. 5.1.2 Post-Procedure Management
  4. 5.1.3 Percutaneous Coronary Intervention (PCI)
  5. 5.2 Global Polymer Coronary Stents Sales by Application
  6. 5.2.1 Global Polymer Coronary Stents Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Polymer Coronary Stents Sales by Application (2021-2032)
  8. 5.2.3 Global Polymer Coronary Stents Sales Market Share by Application (2021-2032)
  9. 5.3 Global Polymer Coronary Stents Revenue by Application
  10. 5.3.1 Global Polymer Coronary Stents Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Polymer Coronary Stents Revenue by Application (2021-2032)
  12. 5.3.3 Global Polymer Coronary Stents Revenue Market Share by Application (2021-2032)
6 Global Polymer Coronary Stents Sales by Region
  1. 6.1 Global Polymer Coronary Stents Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Polymer Coronary Stents Sales by Region (2021-2032)
  3. 6.2.1 Global Polymer Coronary Stents Sales by Region (2021-2026)
  4. 6.2.2 Global Polymer Coronary Stents Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Polymer Coronary Stents Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Polymer Coronary Stents Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Polymer Coronary Stents Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Polymer Coronary Stents Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Polymer Coronary Stents Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Polymer Coronary Stents Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Polymer Coronary Stents Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Polymer Coronary Stents Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Polymer Coronary Stents Revenue by Region
  1. 7.1 Global Polymer Coronary Stents Revenue by Region
  2. 7.1.1 Global Polymer Coronary Stents Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Polymer Coronary Stents Revenue by Region (2021-2026)
  4. 7.1.3 Global Polymer Coronary Stents Revenue by Region (2027-2032)
  5. 7.1.4 Global Polymer Coronary Stents Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Polymer Coronary Stents Revenue (2021-2032)
  8. 7.2.2 North America Polymer Coronary Stents Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Polymer Coronary Stents Revenue (2021-2032)
  11. 7.3.2 Europe Polymer Coronary Stents Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Polymer Coronary Stents Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Polymer Coronary Stents Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Polymer Coronary Stents Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Polymer Coronary Stents Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Wego Healthcare
  2. 8.1.1 Wego Healthcare Company Information
  3. 8.1.2 Wego Healthcare Business Overview
  4. 8.1.3 Wego Healthcare Polymer Coronary Stents Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Wego Healthcare Polymer Coronary Stents Product Portfolio
  6. 8.1.5 Wego Healthcare Recent Developments
  7. 8.2 Shandong Huaan Biotechnology
  8. 8.2.1 Shandong Huaan Biotechnology Company Information
  9. 8.2.2 Shandong Huaan Biotechnology Business Overview
  10. 8.2.3 Shandong Huaan Biotechnology Polymer Coronary Stents Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Shandong Huaan Biotechnology Polymer Coronary Stents Product Portfolio
  12. 8.2.5 Shandong Huaan Biotechnology Recent Developments
  13. 8.3 SINOMED
  14. 8.3.1 SINOMED Company Information
  15. 8.3.2 SINOMED Business Overview
  16. 8.3.3 SINOMED Polymer Coronary Stents Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 SINOMED Polymer Coronary Stents Product Portfolio
  18. 8.3.5 SINOMED Recent Developments
  19. 8.4 Translumina Therapeutics
  20. 8.4.1 Translumina Therapeutics Company Information
  21. 8.4.2 Translumina Therapeutics Business Overview
  22. 8.4.3 Translumina Therapeutics Polymer Coronary Stents Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Translumina Therapeutics Polymer Coronary Stents Product Portfolio
  24. 8.4.5 Translumina Therapeutics Recent Developments
  25. 8.5 SLTL Medical
  26. 8.5.1 SLTL Medical Company Information
  27. 8.5.2 SLTL Medical Business Overview
  28. 8.5.3 SLTL Medical Polymer Coronary Stents Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 SLTL Medical Polymer Coronary Stents Product Portfolio
  30. 8.5.5 SLTL Medical Recent Developments
  31. 8.6 Scitech Medical
  32. 8.6.1 Scitech Medical Company Information
  33. 8.6.2 Scitech Medical Business Overview
  34. 8.6.3 Scitech Medical Polymer Coronary Stents Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Scitech Medical Polymer Coronary Stents Product Portfolio
  36. 8.6.5 Scitech Medical Recent Developments
  37. 8.7 Rontis
  38. 8.7.1 Rontis Company Information
  39. 8.7.2 Rontis Business Overview
  40. 8.7.3 Rontis Polymer Coronary Stents Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Rontis Polymer Coronary Stents Product Portfolio
  42. 8.7.5 Rontis Recent Developments
  43. 8.8 REVA Medical
  44. 8.8.1 REVA Medical Company Information
  45. 8.8.2 REVA Medical Business Overview
  46. 8.8.3 REVA Medical Polymer Coronary Stents Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 REVA Medical Polymer Coronary Stents Product Portfolio
  48. 8.8.5 REVA Medical Recent Developments
  49. 8.9 Purple Microport
  50. 8.9.1 Purple Microport Company Information
  51. 8.9.2 Purple Microport Business Overview
  52. 8.9.3 Purple Microport Polymer Coronary Stents Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Purple Microport Polymer Coronary Stents Product Portfolio
  54. 8.9.5 Purple Microport Recent Developments
  55. 8.10 Meril Life
  56. 8.10.1 Meril Life Company Information
  57. 8.10.2 Meril Life Business Overview
  58. 8.10.3 Meril Life Polymer Coronary Stents Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Meril Life Polymer Coronary Stents Product Portfolio
  60. 8.10.5 Meril Life Recent Developments
  61. 8.11 InSitu Technologies
  62. 8.11.1 InSitu Technologies Company Information
  63. 8.11.2 InSitu Technologies Business Overview
  64. 8.11.3 InSitu Technologies Polymer Coronary Stents Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 InSitu Technologies Polymer Coronary Stents Product Portfolio
  66. 8.11.5 InSitu Technologies Recent Developments
  67. 8.12 HEALTHCARE TECHNOLOGY
  68. 8.12.1 HEALTHCARE TECHNOLOGY Company Information
  69. 8.12.2 HEALTHCARE TECHNOLOGY Business Overview
  70. 8.12.3 HEALTHCARE TECHNOLOGY Polymer Coronary Stents Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 HEALTHCARE TECHNOLOGY Polymer Coronary Stents Product Portfolio
  72. 8.12.5 HEALTHCARE TECHNOLOGY Recent Developments
  73. 8.13 Eucatech
  74. 8.13.1 Eucatech Company Information
  75. 8.13.2 Eucatech Business Overview
  76. 8.13.3 Eucatech Polymer Coronary Stents Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Eucatech Polymer Coronary Stents Product Portfolio
  78. 8.13.5 Eucatech Recent Developments
  79. 8.14 Elixir Medical
  80. 8.14.1 Elixir Medical Company Information
  81. 8.14.2 Elixir Medical Business Overview
  82. 8.14.3 Elixir Medical Polymer Coronary Stents Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Elixir Medical Polymer Coronary Stents Product Portfolio
  84. 8.14.5 Elixir Medical Recent Developments
  85. 8.15 CeloNova BioSciences
  86. 8.15.1 CeloNova BioSciences Company Information
  87. 8.15.2 CeloNova BioSciences Business Overview
  88. 8.15.3 CeloNova BioSciences Polymer Coronary Stents Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 CeloNova BioSciences Polymer Coronary Stents Product Portfolio
  90. 8.15.5 CeloNova BioSciences Recent Developments
  91. 8.16 Biotronik
  92. 8.16.1 Biotronik Company Information
  93. 8.16.2 Biotronik Business Overview
  94. 8.16.3 Biotronik Polymer Coronary Stents Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Biotronik Polymer Coronary Stents Product Portfolio
  96. 8.16.5 Biotronik Recent Developments
  97. 8.17 AMG International
  98. 8.17.1 AMG International Company Information
  99. 8.17.2 AMG International Business Overview
  100. 8.17.3 AMG International Polymer Coronary Stents Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 AMG International Polymer Coronary Stents Product Portfolio
  102. 8.17.5 AMG International Recent Developments
  103. 8.18 Amaranth Medical Analytics
  104. 8.18.1 Amaranth Medical Analytics Company Information
  105. 8.18.2 Amaranth Medical Analytics Business Overview
  106. 8.18.3 Amaranth Medical Analytics Polymer Coronary Stents Sales, Price, Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Amaranth Medical Analytics Polymer Coronary Stents Product Portfolio
  108. 8.18.5 Amaranth Medical Analytics Recent Developments
  109. 8.19 Alvimedica
  110. 8.19.1 Alvimedica Company Information
  111. 8.19.2 Alvimedica Business Overview
  112. 8.19.3 Alvimedica Polymer Coronary Stents Sales, Price, Revenue and Gross Margin (2021-2026)
  113. 8.19.4 Alvimedica Polymer Coronary Stents Product Portfolio
  114. 8.19.5 Alvimedica Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Polymer Coronary Stents Value Chain Analysis
  2. 9.1.1 Polymer Coronary Stents Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Polymer Coronary Stents Production Mode & Process
  6. 9.2 Polymer Coronary Stents Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Polymer Coronary Stents Distributors
  9. 9.2.3 Polymer Coronary Stents Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst